j.moreau
TL2 · Rosario
Contributes reviews on supplier material. Based in Rosario.
Joined 5 May 2025 · last posted 6d
73 posts, newest first. Showing up to 150.
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one Replied, post #17 · Compounds › Oral incretins · 22 Jul 2026 · 0 likes Adding the measurement that post #16 says would settle it. Taking the oral product with more water than instructed reduces absorption rather than helping it. That is…
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #58 · Analytics › HPLC & UHPLC · 22 Jul 2026 · 1 like Before anything else: what was the gradient, and at what wavelength? Area percent at different wavelengths is not the same number even on the same sample because…
-
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #57 · Clinical › Comorbidities · 20 Jul 2026 · 0 likes Taking post #55 at face value and following it one step further. Where the honest answer is "nobody knows", giving it plainly is more useful than a confident synthesis…
-
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #23 · Compounds › Repair & healing peptides · 10 Jul 2026 · 7 likes Saving this. It is the version I will quote when the question comes round again.
-
[2026 update] Currency conversion and the cost you did not see Replied, post #25 · Sourcing › Payments · 10 Jul 2026 · 20 likes Post #22 is right about the mechanism and I think understates the practical bit. One caution on Currency conversion: everything above assumes the underlying…
-
Packaging that arrived damaged: documenting it properly Replied, post #37 · Sourcing › Logistics · 6 Jul 2026 · 10 likes Peak periods and public holidays affect this more than any other factor and are entirely predictable in advance.
-
Alcohol: what is documented and what is folklore Replied, post #92 · Practice › Interactions · 4 Jul 2026 · 0 likes The most defensible general position in this subcategory: identify the plausible mechanism, check whether it has been studied, and where it has not, say that rather…
-
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #18 · Compounds › Secretagogues & GH axis · 1 Jul 2026 · 6 likes Post #15 put the caveat in the right place and I want to underline it. Marking my uncertainty on Reading a rodent study explicitly. I am confident about the direction,…
-
Pages past their review date, listed — does this still hold? Replied, post #27 · Meta › Wiki maintenance · 27 Jun 2026 · 30 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
-
Coming back to: A structured critique template this community uses Replied, post #38 · Evidence › Study critique · 20 Jun 2026 · 0 likes Picking up post #35: that is the part I would want checked first. Where a critique changes your position, saying so in the thread is worth more than being right, and it…
-
Does dual agonism explain the effect size, or is it dose? Replied, post #31 · Compounds › Tirzepatide · 12 Jun 2026 · 11 likes Worth separating dual agonism as a question about the compound from dual agonism as a question about the documentation. They get answered by different people and only…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #90 · Sourcing › Logistics · 3 Jun 2026 · 1 like Confirming post #87 from a second method, which matters more than confirming it from a second person. On Regional warehouse stock versus direct, I would rather…
-
Two scans six weeks apart on different machines: a cautionary tale Replied, post #21 · Outcomes › Body composition · 18 May 2026 · 21 likes Visceral fat: DXA does not distinguish visceral (organ-associated) fat from subcutaneous fat. That distinction might matter but requires different imaging to measure. I…
-
Research-use-only status: what it means legally and practically Replied, post #38 · Compounds › Other compounds · 6 May 2026 · 0 likes Worth separating research-use-only status as a question about the compound from research-use-only status as a question about the documentation. They get answered by…
-
Two scans six weeks apart on different machines: a cautionary tale Replied, post #10 · Outcomes › Body composition · 2 May 2026 · 0 likes Quietly grateful for the plain phrasing. Not every thread gets that.
-
About the Interactions category Replied, post #7 · Practice › Interactions · 1 May 2026 · 7 likes Delayed gastric emptying is the mechanism behind most of the plausible interactions in this class: anything whose absorption depends on how quickly the stomach empties…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #46 · Compounds › Semaglutide · 29 Apr 2026 · 1 like On molecular mass of semaglutide I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating…
-
Hair shedding at month three: mechanism and time course — the long version Replied, post #2 · Practice › Side effects · 22 Apr 2026 · 11 likes The opening post is right about the mechanism and I think understates the practical bit. Slowed gastric emptying is the mechanism behind most of the early symptoms.…
-
Spike-and-recover accuracy for a peptide assay Replied, post #32 · Analytics › Method validation · 8 Apr 2026 · 5 likes Post #31 is right about the mechanism and I think understates the practical bit. Accuracy for a purity assay is usually demonstrated by spike recovery across a range.…
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #101 · Regional › UK & Ireland · 2 Apr 2026 · 2 likes Shortage positions have moved several times and any statement about supply here should carry a date on the face of it. The disagreement above is smaller than it looks…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #143 · Access › International · 4 Mar 2026 · 17 likes Regulatory position dates: a regulatory position is only current as of when it was written. Rechecking is prudent, especially if you saw it months ago.
-
Transporting a vial for a weekend away — a second dataset Started this topic · Practice › Storage & stability · 28 Feb 2026 · 30 likes Transporting a vial for a weekend away — a second dataset Writing it up because I had to work it out twice and would rather nobody else did. Posting a small dataset on…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #105 · Analytics › Mass spectrometry · 15 Feb 2026 · 6 likes For a compound with no reference standard in circulation, an observed mass is much more useful than an assertion of agreement with a theoretical value nobody can check.
-
A widely repeated interaction claim that turns out to be unsupported Replied, post #27 · Practice › Interactions · 12 Feb 2026 · 0 likes Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #29 · Outcomes › Progress reports · 10 Feb 2026 · 27 likes Marking my uncertainty on Seven-day rolling explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it…
-
Distinguishing a red flag from an inconvenience Replied, post #2 · Sourcing › Red flags · 29 Jan 2026 · 29 likes This follows the opening post rather than contradicting it. Evasion when asked: if a supplier does not clarify when asked specifically for method details, counter-ion…
-
What "verified" means on our vendor pages, stated narrowly Replied, post #22 · Sourcing › Vendor reports · 30 Dec 2025 · 0 likes Reports of ordinary results are more valuable than reports of remarkable ones, precisely because only the remarkable ones get posted elsewhere. That is the version I…
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #22 · Sourcing › Red flags · 21 Dec 2025 · 0 likes On supplier, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the range is the interesting…
-
Coming back to: "Greater than or equal to 99%" as a specification rather than a result Replied, post #2 · Analytics › COA interpretation · 21 Dec 2025 · 0 likes A certificate of analysis is a statement by its issuer that a defined test was performed on a defined lot and produced a defined result. That is all it is, and it is…
-
Lyophilisation and why the cake looks the way it does Replied, post #30 · Pharmacology › Formulation chemistry · 18 Dec 2025 · 1 like That reframing is the whole thing. The facts I already had.
-
Whether protein timing matters at a large deficit Replied, post #7 · Nutrition & Training › Protein & intake · 7 Dec 2025 · 0 likes Meeting protein targets on suppressed appetite: this is where the practical difficulty lies. Eating more protein when appetite is suppressed is genuinely hard.…
-
Robustness: the parameters worth deliberately varying Replied, post #24 · Analytics › Method validation · 27 Nov 2025 · 29 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #56 · Analytics › Home & field testing · 17 Nov 2025 · 19 likes Post #55 is right about the mechanism and I think understates the practical bit. Weighing vials against declared fill is the most underrated home check available. It…
-
Reading a supplier's product description as a marketing document Replied, post #98 · Compounds › Other compounds · 14 Nov 2025 · 10 likes Narrowing post #95, because the general version has more than one answer. When "no data" is the complete and final answer: if there is no published human data on a…
-
Cardiovascular risk: reading the outcome trials as a set Started this topic · Clinical › Comorbidities · 9 Nov 2025 · 26 likes Cardiovascular risk: reading the outcome trials as a set Writing it up because I had to work it out twice and would rather nobody else did. Reading back through what…
-
Follow-up: What a seizure notice actually says Replied, post #12 · Sourcing › Logistics · 24 Oct 2025 · 14 likes Understood, and I withdraw the assumption I opened with.
-
Revisiting: German, French and Dutch differences, compared Replied, post #87 · Regional › European Union · 15 Oct 2025 · 0 likes This follows post #84 rather than contradicting it. What I would tell a new member reading about German for the first time: the confident posts are not the reliable…
-
Specification in the result column: why that is a meaningful error Replied, post #54 · Analytics › COA interpretation · 6 Oct 2025 · 27 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #39 · Analytics › COA interpretation · 21 Sep 2025 · 1 like Post #36 is right about the mechanism and I think understates the practical bit. An itemised related-substances table with retention times says considerably more about…
-
Temperature loggers worth the money — the long version Replied, post #30 · Devices › Cold chain · 25 Aug 2025 · 26 likes Useful. I have added it to my own notes with the date on it.
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #37 · Analytics › HPLC & UHPLC · 15 Aug 2025 · 0 likes Post #35 put the caveat in the right place and I want to underline it. Speaking only to Resolution and tailing factor as I have actually seen it, rather than as it is…
-
Are there stupid questions here? A staff answer, at length Replied, post #2 · Start Here › Welcome · 20 Jul 2025 · 4 likes Your introduction is well framed. You have given enough context that people can actually answer. That is rarer than it sounds and it matters more than it sounds.…
-
Why quantitation is the hard part, not detection Replied, post #16 · Analytics › Home & field testing · 19 Jul 2025 · 19 likes Quantitation at home is the part that does not survive scrutiny. Precision adequate to distinguish 96 from 98 per cent requires instrumentation and calibration that a…
-
What this community means by "a source", in practical terms Replied, post #26 · Start Here › Welcome · 6 Jul 2025 · 32 likes If you want a fast orientation, read three solved topics in the subcategory you care about. Solved means somebody said the answer worked, which is more signal than…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #19 · Practice › Reconstitution · 1 Jul 2025 · 3 likes The arithmetic on decimal-point error is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will catch it.
-
A ten-fold dose error caught before injection Replied, post #53 · Devices › Syringes & needles · 22 Jun 2025 · 1 like If you are new and reading this thread for the answer to ten-fold dose error caught: the answer is conditional, the conditions are in the third reply, and the rest of…
-
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #13 · Compounds › Secretagogues & GH axis · 7 Jun 2025 · 1 like Two sentences on reading a rodent study and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is narrow. What…
-
Specification in the result column: why that is a meaningful error Replied, post #6 · Analytics › COA interpretation · 6 Jun 2025 · 0 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #18 · Data & Tools › Calculators · 5 Jun 2025 · 3 likes Coming back to post #15, because the follow-up matters more than the original answer. A saved calculation is worth more than a remembered one. Write down the inputs…
-
A comparison of home results against a laboratory result on the same vial Replied, post #3 · Analytics › Home & field testing · 4 Jun 2025 · 17 likes Building on the opening post rather than restating it. The most useful home practice is not a test at all: photograph the vial, the cake, the label and the document on…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #2 · Compounds › Cagrilintide & amylin analogues · 2 Jun 2025 · 8 likes What would change my mind on CagriSema phase 2 paper is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would…
-
Subcutaneous absorption kinetics and site differences Replied, post #6 · Pharmacology › Pharmacokinetics · 1 Jun 2025 · 4 likes Where I part company with post #2, and it is a narrow parting. A pharmacokinetic model fitted to trial data describes the population studied. Applying it to somebody…
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #13 · Evidence › Journal club · 23 May 2025 · 14 likes Taking post #12 at face value and following it one step further. The most common failure mode is spending fifty minutes on the effect size and ten on the population.…
-
Pregnancy as an absolute contraindication Replied, post #90 · Safety › Contraindications · 20 May 2025 · 0 likes Prior hypersensitivity to the product or its excipients is a contraindication that people forget applies to the excipients too.
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #31 · Clinical › Comorbidities · 2 May 2025 · 1 like Adding thanks rather than a view. I do not have a view worth the space.
-
Hello from a laboratory that does not do peptides Replied, post #2 · Lounge › Introductions · 19 Apr 2025 · 2 likes Say hello. No question required. Introduce yourself if you want to give context for why you are here, or just introduce yourself because you like meeting people.…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #62 · Compounds › Tirzepatide · 16 Apr 2025 · 11 likes The arithmetic in post #59 is right; the assumption feeding it is the part to check. The five maintenance doses in the tirzepatide programme give a genuine…
-
Carryover and the ghost peak from last week's standard Replied, post #3 · Analytics › HPLC & UHPLC · 31 Mar 2025 · 0 likes A methods point on carryover rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference in method.
-
Second pass at: Gauge and length selection for subcutaneous injection Replied, post #48 · Devices › Syringes & needles · 30 Mar 2025 · 0 likes I disagree with the framing of Gauge and length selection above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it…
-
Follow-up: What other technical communities get right that we do not Replied, post #43 · Lounge › Off topic · 19 Mar 2025 · 0 likes Not a rules-free zone: the guidelines still apply. No contact details, no invitations to take a conversation off the site, no endorsements of other communities. Just a…
-
The topic list is dense — is that deliberate? Replied, post #92 · Meta › Site feedback · 1 Feb 2025 · 0 likes Distinguishing three things in the topic list discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the recommendation that…
-
Second pass at: Historical amylin analogues and what happened to them Replied, post #17 · Compounds › Cagrilintide & amylin analogues · 20 Jan 2025 · 11 likes Building on post #16 rather than restating it. My understanding of Historical amylin analogues is a few years old and may have been superseded. If it has been, I would…
-
A 10 mg vial reconstituted three different ways, compared — the long version Started this topic · Practice › Reconstitution · 10 Jan 2025 · 17 likes A 10 mg vial reconstituted three different ways, compared — the long version — setting out what I have, and where I think it stops being reliable. Asking about 10 mg…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #59 · Compounds › Other compounds · 8 Jan 2025 · 15 likes Post #56 answers the question as asked. The question underneath it is different. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #24 · Compounds › Semaglutide · 19 Dec 2024 · 3 likes Practical answer on Molecular mass of semaglutide, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide…
-
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #54 · Nutrition & Training › Protein & intake · 13 Dec 2024 · 0 likes Building on post #51 rather than restating it. The question underneath Meeting a protein target is usually "how would I tell?" rather than "what is true?", and that one…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #83 · Compounds › Tirzepatide · 12 Dec 2024 · 0 likes On post #80 — agreed on the reasoning, with one qualification. Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #24 · Compounds › Cagrilintide & amylin analogues · 18 Nov 2024 · 21 likes This follows post #23 rather than contradicting it. Comparing an amylin analogue to an incretin agonist on weight change alone misses that they were developed to be…
-
Time to steady state after a dose increase Replied, post #61 · Pharmacology › Pharmacokinetics · 4 Nov 2024 · 5 likes Between-person variability in exposure is substantial and is the reason two people on the same dose can have quite different plasma concentrations. That is inherent…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #120 · Clinical › Comorbidities · 28 Oct 2024 · 12 likes No notes. Posting so the count is not one.
-
Criticising the method without criticising the authors Replied, post #4 · Evidence › Study critique · 7 Sep 2024 · 31 likes Multiple comparisons without adjustment is a defensible choice when declared in advance and a problem when discovered afterwards. The registry entry settles which…
-
Circumference measurements as a poor man's composition estimate Replied, post #43 · Outcomes › Body composition · 5 Aug 2024 · 9 likes Report the method with the number, always. A composition figure without the method is not comparable to anything, including your own previous figure. That is all the…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #74 · Compounds › Retatrutide · 21 Jul 2024 · 0 likes Retatrutide dose escalation: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I would…